Literature DB >> 17276544

Treatment of extensive cutaneous metastatic melanoma with topical diphencyprone.

Diona L Damian1, John F Thompson.   

Abstract

Diphencyprone is a potent contact sensitizer sometimes used to treat alopecia areata and cutaneous warts. A patient with previous primary nodular melanoma on the scalp developed extensive, confluent cutaneous metastases near the primary site, unsuitable for treatment with surgery or radiotherapy. Topical treatment with diphencyprone as a single agent resulted in regression of all lesions, and the patient remains well 18 months later. Topical immunotherapy with diphencyprone was an inexpensive and well-tolerated treatment for extensive cutaneous melanoma metastases in our patient unsuitable for other therapies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17276544     DOI: 10.1016/j.jaad.2006.12.018

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  12 in total

1.  A novel reporter system for molecular imaging and high-throughput screening of anticancer drugs.

Authors:  Jingping Xie; Chunxia Wang; John Virostko; H Charles Manning; Wellington Pham; Joshua Bauer; John C Gore
Journal:  Chembiochem       Date:  2013-07-24       Impact factor: 3.164

Review 2.  Current treatment of locoregional recurrence of melanoma.

Authors:  Malcolm Hart Squires; Keith A Delman
Journal:  Curr Oncol Rep       Date:  2013-10       Impact factor: 5.075

3.  Generalized molluscum contagiosum in an HIV patient treated with diphencyprone.

Authors:  Leena Chularojanamontri; Papapit Tuchinda; Kanokvalai Kulthanan; Woraphong Manuskiatti
Journal:  J Dermatol Case Rep       Date:  2010-12-31

4.  Topical diphencyprone as an effective treatment for cutaneous metastatic melanoma.

Authors:  Young Jin Kim
Journal:  Ann Dermatol       Date:  2012-07-25       Impact factor: 1.444

5.  TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone.

Authors:  Frank Martiniuk; Diona L Damian; John F Thompson; Richard A Scolyer; Kam-Meng Tchou-Wong; William R Levis
Journal:  J Drugs Dermatol       Date:  2010-11       Impact factor: 2.114

Review 6.  Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata.

Authors:  Kun-Wei Lai; Tsen-Fang Tsai
Journal:  Dermatol Ther (Heidelb)       Date:  2022-09-22

7.  Effective topical treatment of subcutaneous murine B16F10-Nex2 melanoma by the antimicrobial peptide gomesin.

Authors:  Elaine G Rodrigues; Andrey Ss Dobroff; Clarissa F Cavarsan; Thaysa Paschoalin; Leonardo Nimrichter; Renato A Mortara; Edson Lucas Santos; Marcos A Fázio; Antonio Miranda; Sirlei Daffre; Luiz R Travassos
Journal:  Neoplasia       Date:  2008-01       Impact factor: 5.715

Review 8.  Developments in Intralesional Therapy for Metastatic Melanoma.

Authors:  Sarah Sloot; Omar M Rashid; Arnod A Sarnaik; Jonathan S Zager
Journal:  Cancer Control       Date:  2016-01       Impact factor: 3.302

9.  Acute Truncal Lymphedema Secondary to Axillary Metastatic Melanoma Presenting Like Cellulitis.

Authors:  Shelley J E Hwang; Benjamin Y Kong; Shaun Chou; Deepal Wakade; Matteo S Carlino; Pablo Fernandez-Penas
Journal:  Case Rep Med       Date:  2017-01-15

10.  Treatment of in-transit melanoma with intralesional bacillus Calmette-Guérin (BCG) and topical imiquimod 5% cream: a report of 3 cases.

Authors:  Nour Kibbi; Stephan Ariyan; Mark Faries; Jennifer N Choi
Journal:  J Immunother       Date:  2015 Nov-Dec       Impact factor: 4.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.